Bromocriptine mesylate
Drug ingredientCAS 22260-51-1
This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
US productionNot reported
Top sourceNo public record
This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.
Why supply is unknownWhere It Comes From
EPA and Census publish no US supply data for this chemical.
12 FDA-registered drug labelers
ANI Pharmaceuticals, Inc.
Avvisto Therapeutics LLC
Curia Italy S.r.l.
Mylan Pharmaceuticals Inc.
Padagis US LLC
Professional Compounding Centers of America dba PCCA
Qingdao Biopeptek Co., Ltd.
Sandoz Inc
TAPI Czech Industries s.r.o.
Teva Czech Industries s.r.o
Zydus Lifesciences Limited
Zydus Pharmaceuticals USA Inc.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 2 drug and cosmetic product listings (FDA).
- •Bromocriptine Mesylate
- •Cycloset
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS22260-51-1
PubChem CID31100
DTXSIDDTXSID6020197
FormulaC33H44BrN5O8S
Mol. Weight750.7 g/mol
SMILESCC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CN(C5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O.CS(=O)(=O)O
Data Sources
- PubChem · compound 31100Retrieved 2026-04-07
- FDA National Drug Code directoryRetrieved 2026-04-25
- FDA National Drug Code directoryRetrieved 2026-04-07
Brief citations
Bromocriptine mesylate (CAS 22260-51-1) https://chemicalindependence.com/chemical/22260-51-1/ PubChem: 31100. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/31100 FDA National Drug Code directory: CAS 22260-51-1. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA National Drug Code directory: bulk match. Retrieved 2026-04-07. https://open.fda.gov/data/ndc/